Eurofins adds radiolabelling service with CRO acquisition

By Flora Southey contact

- Last updated on GMT

(Image: Getty/Kritchanut)
(Image: Getty/Kritchanut)

Related tags: Pharmacology

Eurofins Scientific has incorporated radiolabelling services and boosted drug discovery capabilities to following the acquisition of UK CRO Selcia.

Under the agreement, the analytical testing firm will take on Selcia’s 2,500m² research and development laboratories in Ongar, UK, where it houses its medicinal chemistry and peptidyl prolyl isomerase (PPIase) inhibitor screening platform.

Eurofins will also integrate the contract research organization’s (CRO) radiolabelling capabilities to test compounds’ metabolism and utilization.

“Selcia’s focus on quality and world leading carbon-14 (14C) radiolabelling capabilities, including GLP analytical and GMP API manufacturing, fills a strategic gap in Eurofins’ global offering in the highly attractive pharmaceutical and agroscience testing markets,” ​said Eurofins’ Klaus Kuegler.

According to Selcia, the acquisition, terms of which were not disclosed, offers Eurofins a more comprehensive drug discovery service, “including innovative hit to lead and lead optimization, medicinal chemistry, assay development and screening.”

Selcia’s 70 employees – which work across analytical, medicinal and synthetic radiochemistry, and biology areas – will also work under the Eurofins, a Selcia spokesperson told us.

“Selcia will continue to independently foster relationships with new and existing customers as well as with Eurofins’ worldwide network of laboratories,” ​said Selcia’s COO Clive Cornell.

The acquisition is the latest in a list of recent takeovers for Eurofins.

In 2016, Eurofins acquired US analytical services firm Advantar Laboratories​, Australian QC company ams​, and Dutch QC services firm Sinensis Life Science​.

Eurofins also bought Canadian drug ingredient manufacturing and testing contractor Alphora Research​ and India-based preclinical CRO Advinus Therapeutics​ in 2016.

Related news

Show more

Related products

show more

Has EDC Kept Up With Changes In Clinical Trials?

Has EDC Kept Up With Changes In Clinical Trials?

Oracle Health Sciences | 14-Dec-2020 | Technical / White Paper

In just a few decades, clinical trials have changed dramatically. Twenty years ago, most of the data used in clinical research was entered on paper, but...

Liver Disease Capabilities

Liver Disease Capabilities

Q² Solutions | 01-Oct-2020 | Clinical Study

We integrate therapeutic insights, state-of-the-art technologies, best-in-class methods and quality systems to optimize NAFLD & NASH study design,...

CAR-T Cell Therapy

CAR-T Cell Therapy

Q² Solutions | 01-Sep-2020 | Clinical Study

Cell therapy involves the transfer of genetically altered cells into a patient. As a global central laboratory services organization, we provide testing...

Related suppliers

Follow us


View more